vs
Cytek Biosciences, Inc.（CTKB）与Riley Exploration Permian, Inc.（REPX）财务数据对比。点击上方公司名可切换其他公司
Riley Exploration Permian, Inc.的季度营收约是Cytek Biosciences, Inc.的1.6倍（$97.3M vs $62.1M），Cytek Biosciences, Inc.同比增速更快（8.1% vs -5.3%），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs -1.2%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Riley Exploration Permian, Inc.是一家独立能源企业，专注于美国得克萨斯州与新墨西哥州境内的二叠纪盆地，开展原油、天然气及天然气凝析液的勘探、开发与生产业务，主打低成本陆上储备开发，为北美市场供应稳定能源产品。
CTKB vs REPX — 直观对比
营收规模更大
REPX
是对方的1.6倍
$62.1M
营收增速更快
CTKB
高出13.4%
-5.3%
两年增速更快
CTKB
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $97.3M |
| 净利润 | $-44.1M | — |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 26.9% |
| 净利率 | -70.9% | — |
| 营收同比 | 8.1% | -5.3% |
| 净利润同比 | -557.1% | — |
| 每股收益（稀释后） | — | $4.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBREPX
| Q4 25 | $62.1M | $97.3M | ||
| Q3 25 | $52.3M | $106.9M | ||
| Q2 25 | $45.6M | $85.4M | ||
| Q1 25 | $41.5M | $102.5M | ||
| Q4 24 | $57.5M | $102.7M | ||
| Q3 24 | $51.5M | $102.3M | ||
| Q2 24 | $46.6M | $105.4M | ||
| Q1 24 | $44.9M | $99.7M |
净利润CTKBREPX
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $16.3M | ||
| Q2 25 | $-5.6M | $30.5M | ||
| Q1 25 | $-11.4M | $28.6M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $25.7M | ||
| Q2 24 | $-10.4M | $33.5M | ||
| Q1 24 | $-6.2M | $18.8M |
毛利率CTKBREPX
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBREPX
| Q4 25 | -9.0% | 26.9% | ||
| Q3 25 | -17.6% | 27.0% | ||
| Q2 25 | -23.3% | 33.7% | ||
| Q1 25 | -36.1% | 48.3% | ||
| Q4 24 | 5.2% | 31.2% | ||
| Q3 24 | -8.2% | 17.1% | ||
| Q2 24 | -18.3% | 50.9% | ||
| Q1 24 | -23.9% | 50.7% |
净利率CTKBREPX
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 15.3% | ||
| Q2 25 | -12.2% | 35.7% | ||
| Q1 25 | -27.5% | 27.9% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 25.1% | ||
| Q2 24 | -22.4% | 31.8% | ||
| Q1 24 | -13.8% | 18.8% |
每股收益（稀释后）CTKBREPX
| Q4 25 | — | $4.02 | ||
| Q3 25 | — | $0.77 | ||
| Q2 25 | — | $1.44 | ||
| Q1 25 | — | $1.36 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $1.59 | ||
| Q1 24 | — | $0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | — |
| 总债务越低越好 | — | $247.9M |
| 股东权益账面价值 | $341.7M | $634.2M |
| 总资产 | $461.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.39× |
8季度趋势，按日历期对齐
现金及短期投资CTKBREPX
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
总债务CTKBREPX
| Q4 25 | — | $247.9M | ||
| Q3 25 | — | $367.0M | ||
| Q2 25 | — | $275.2M | ||
| Q1 25 | — | $249.3M | ||
| Q4 24 | — | $269.5M | ||
| Q3 24 | — | $288.6M | ||
| Q2 24 | — | $322.7M | ||
| Q1 24 | — | $341.8M |
股东权益CTKBREPX
| Q4 25 | $341.7M | $634.2M | ||
| Q3 25 | $378.6M | $566.5M | ||
| Q2 25 | $377.6M | $556.9M | ||
| Q1 25 | $379.6M | $532.4M | ||
| Q4 24 | $395.7M | $510.6M | ||
| Q3 24 | $385.5M | $507.4M | ||
| Q2 24 | $389.1M | $489.0M | ||
| Q1 24 | $392.6M | $434.6M |
总资产CTKBREPX
| Q4 25 | $461.5M | $1.2B | ||
| Q3 25 | $494.9M | $1.2B | ||
| Q2 25 | $493.3M | $1.0B | ||
| Q1 25 | $482.6M | $994.9M | ||
| Q4 24 | $499.5M | $993.5M | ||
| Q3 24 | $491.2M | $997.9M | ||
| Q2 24 | $483.7M | $1.0B | ||
| Q1 24 | $492.1M | $956.4M |
负债/权益比CTKBREPX
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.49× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.57× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $64.9M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBREPX
| Q4 25 | $-771.0K | $64.9M | ||
| Q3 25 | $-3.9M | $63.6M | ||
| Q2 25 | $108.0K | $33.6M | ||
| Q1 25 | $-125.0K | $50.4M | ||
| Q4 24 | $2.0M | $66.4M | ||
| Q3 24 | $13.2M | $72.1M | ||
| Q2 24 | $6.2M | $51.6M | ||
| Q1 24 | $4.0M | $56.1M |
自由现金流CTKBREPX
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
自由现金流率CTKBREPX
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度CTKBREPX
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率CTKBREPX
| Q4 25 | — | — | ||
| Q3 25 | — | 3.90× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.76× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 2.81× | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | — | 2.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
REPX
暂无分部数据
